Merck to Participate in the 8th Annual Evercore ISI HealthCONx Conference

Core Points - Merck will participate in the 8th Annual Evercore ISI HealthCONx Conference on December 2, 2025, featuring Chirfi Guindo and Dr. Eliav Barr [1] - A live audio webcast of the presentation will be available for investors, analysts, and the public [2] - Merck aims to be a leading research-intensive biopharmaceutical company, focusing on innovative health solutions and a diverse workforce [3] Company Overview - Merck, known as MSD outside the U.S. and Canada, has over 130 years of experience in developing important medicines and vaccines [3] - The company is committed to advancing clinical research in hematology and has an expanding pipeline of investigational candidates [7]